Exploiting bi-specific engagement: assessing monovalent vs bivalent binding

Original language	English
Publication status	Published - 23 Apr 2024
Event	Immuno-oncology Summit Europe 2024 - London, United Kingdom Duration: 23 Apr 2024 → 25 Apr 2024 https://www.immuno-oncologyeurope.com/

Conference

Conference	Immuno-oncology Summit Europe 2024
Country/Territory	United Kingdom
City	London
Period	23/04/24 → 25/04/24
Internet address	https://www.immuno-oncologyeurope.com/

Keywords

• antibody
• bispecific
• bivalent binding

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 
• 

Projects

• 1 Active

Projects per year

• Understanding the relationship between target affinities of bi-specific antibodies to dual cell-membrane targets and their impact on cell binding and selectivity to improve the accuracy and value of in silico modelling for prediction of the optimal target affinities for effective clinical outcomes

  Rattray, Z., Beveridge, R. & Duxbury, R.

  1/10/22 → 31/03/26

  Project: Research - Studentship

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Duxbury, R., Beveridge, R., Jamieson, C., Jones, D., Jones, G., & Rattray, Z. (2024). Exploiting bi-specific engagement: assessing monovalent vs bivalent binding. Poster session presented at Immuno-oncology Summit Europe 2024, London, United Kingdom.

Duxbury, Rachel ; Beveridge, Rebecca ; Jamieson, Craig et al. / Exploiting bi-specific engagement : assessing monovalent vs bivalent binding. Poster session presented at Immuno-oncology Summit Europe 2024, London, United Kingdom.

@conference{f75e9eb69c534a4f96334926154930f5,

title = "Exploiting bi-specific engagement: assessing monovalent vs bivalent binding",

keywords = "antibody, bispecific, bivalent binding",

author = "Rachel Duxbury and Rebecca Beveridge and Craig Jamieson and David Jones and Gavin Jones and Zahra Rattray",

year = "2024",

month = apr,

day = "23",

language = "English",

note = "Immuno-oncology Summit Europe 2024 ; Conference date: 23-04-2024 Through 25-04-2024",

url = "https://www.immuno-oncologyeurope.com/",

}

Duxbury, R, Beveridge, R, Jamieson, C, Jones, D, Jones, G & Rattray, Z 2024, 'Exploiting bi-specific engagement: assessing monovalent vs bivalent binding', Immuno-oncology Summit Europe 2024, London, United Kingdom, 23/04/24 - 25/04/24.

Exploiting bi-specific engagement: assessing monovalent vs bivalent binding. / Duxbury, Rachel; Beveridge, Rebecca; Jamieson, Craig et al.
2024. Poster session presented at Immuno-oncology Summit Europe 2024, London, United Kingdom.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Exploiting bi-specific engagement

T2 - Immuno-oncology Summit Europe 2024

AU - Duxbury, Rachel

AU - Beveridge, Rebecca

AU - Jamieson, Craig

AU - Jones, David

AU - Jones, Gavin

AU - Rattray, Zahra

PY - 2024/4/23

Y1 - 2024/4/23

KW - antibody

KW - bispecific

KW - bivalent binding

M3 - Poster

Y2 - 23 April 2024 through 25 April 2024

ER -

Duxbury R, Beveridge R, Jamieson C, Jones D, Jones G, Rattray Z. Exploiting bi-specific engagement: assessing monovalent vs bivalent binding. 2024. Poster session presented at Immuno-oncology Summit Europe 2024, London, United Kingdom.